TearLab (TearLab) Cash-to-Debt : 0.19 (As of Mar. 2020)

View and export this data going back to 2004. Start your Free Trial

What is TearLab Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. TearLab's cash to debt ratio for the quarter that ended in Mar. 2020 was 0.19.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, TearLab couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2020.

The historical rank and industry rank for TearLab's Cash-to-Debt or its related term are showing as below:

TEAR's Cash-to-Debt is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 1.35
* Ranked among companies with meaningful Cash-to-Debt only.

TearLab Cash-to-Debt Historical Data

The historical data trend for TearLab's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

TearLab Cash-to-Debt Chart

TearLab Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Cash-to-Debt

Get a 7-Day Free Trial

0.56

0.59

0.26

0.27

0.19

TearLab Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20
Cash-to-Debt	Get a 7-Day Free Trial															0.26	0.26	0.25	0.19	0.19

Competitive Comparison of TearLab's Cash-to-Debt

For the Diagnostics & Research subindustry, TearLab's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TearLab's Cash-to-Debt Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, TearLab's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where TearLab's Cash-to-Debt falls into.

TearLab Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

TearLab's Cash to Debt Ratio for the fiscal year that ended in Dec. 2019 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	7.108	/	(36.818	+	0.429)
	=	0.19

TearLab's Cash to Debt Ratio for the quarter that ended in Mar. 2020 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	7.335	/	(38.225	+	0.392)
	=	0.19

TearLab (OTCPK:TEAR) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

TearLab Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of TearLab's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

TearLab (TearLab) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » TearLab Corp (OTCPK:TEAR) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

150 LaTerraza Boulevard, SuiteÂ 101, Escondido, CA, USA, 92025

Website

http://www.tearlab.com

TearLab Corp is a part of the diagnostic industry. It is an in-vitro diagnostic company based in the United States. TearLab has commercialized a proprietary tear testing platform, the TearLab Osmolarity System that enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The company operates through its wholly-owned subsidiary, TearLab Research Inc. Most of the company's revenue is derived from the United States region.

Executives

Anthony E Altig	director	C/O OPTIMER PHARMACEUTICALS, INC, 101 HUDSON STREET, JERSEY CITY NJ 07302
Cr Group L.p.	10 percent owner	1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Lindstrom Richard L Md	director	2811 WESTWOOD PL, WAYZATA MN 55391
Awm Investment Company, Inc.	10 percent owner	527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Adrienne L Graves	director	125 STONE MOUNTAIN CIRCLE, NAPA CA 94558
Gilbert S Omenn	director	AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
John Y Caloz	officer: Chief Financial Officer	ETON AVE, C/O INTERNATIONAL REMOTE IMAGING SYS, CHATSWORTH CA 91311